Literature DB >> 8804445

Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population.

S Franceschi1, M Geddes.   

Abstract

An excess of classic Kaposi's sarcoma (KS) in individuals of southern European ancestry has long been suspected and recently quantified in terms of age-standardized rates. In Italy and most notably in southern Italy for the period 1976-84, prior to the AIDS epidemic, KS incidence rates were two-to-three-fold higher than in the United States and Sweden and many ten-fold higher than in England and Wales and Australia. A high frequency of classic KS has also been documented in Israel and, in low-risk countries, in individuals born in southern Europe and the Middle East. Many infections have been suspected to play a role in the etiology of KS, including cytomegalovirus, malaria and, most recently, a new virus of the herpes family, identified in AIDS-associated and classic KS. The present review deals with epidemiologic data concerning KS in the Mediterranean and stresses the opportunity to combine the study of KS in AIDS as well as non-AIDS patients in order to shed light on this no longer rare disease.

Entities:  

Mesh:

Year:  1995        PMID: 8804445     DOI: 10.1177/030089169508100502

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  18 in total

1.  A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sadler; L Wu; B Forghani; R Renne; W Zhong; B Herndier; D Ganem
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.

Authors:  Denise Whitby; Vickie A Marshall; Rachel K Bagni; Wendell J Miley; Thomas G McCloud; Rebecca Hines-Boykin; James J Goedert; Betty A Conde; Kunio Nagashima; Judy Mikovits; Dirk P Dittmer; David J Newman
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

Review 4.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

5.  Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Siobhan Sutcliffe; Cathee Till; Frank J Jenkins; Charlotte A Gaydos; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-10-31       Impact factor: 2.506

Review 6.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Correlates of sexually transmitted infection histories in a cohort of American male health professionals.

Authors:  Siobhan Sutcliffe; Ichiro Kawachi; John F Alderete; Charlotte A Gaydos; Lisa P Jacobson; Frank J Jenkins; Raphael P Viscidi; Jonathan M Zenilman; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-08-05       Impact factor: 2.506

8.  A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma.

Authors:  Brahim Aissani; Howard W Wiener; Kui Zhang; Richard A Kaslow; Kisani M Ogwaro; Sadeep Shrestha; Lisa P Jacobson
Journal:  Int J Cancer       Date:  2013-07-27       Impact factor: 7.396

9.  A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.

Authors:  D Serraino; L Toma; M Andreoni; S Buttò; O Tchangmena; L Sarmati; P Monini; S Franceschi; B Ensoli; G Rezza
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

10.  Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.

Authors:  Siobhan Sutcliffe; Edward Giovannucci; Charlotte A Gaydos; Raphael P Viscidi; Frank J Jenkins; Jonathan M Zenilman; Lisa P Jacobson; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.